The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of CN201, a novel CD3xCD19 bispecific antibody, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
 
Yang Xie
No Relationships to Disclose
 
Qingqing Cai
No Relationships to Disclose
 
Haisheng Liu
No Relationships to Disclose
 
Ye Guo
Honoraria - BeiGene; Merck Serono; MSD; Roche
Consulting or Advisory Role - GlaxoSmithKline; Merck Serono; MSD; Roche
 
Wenrong Huang
No Relationships to Disclose
 
Mingzhi Zhang
No Relationships to Disclose
 
Yi Xia
No Relationships to Disclose
 
Yuhuan Gao
No Relationships to Disclose
 
Xilin Chen
No Relationships to Disclose
 
Yongjing Tang
No Relationships to Disclose
 
Shaoning Yin
No Relationships to Disclose
 
Shunzong Yuan
No Relationships to Disclose
 
Haiying Li
Employment - Curon Biopharmaceutical
Stock and Other Ownership Interests - Curon Biopharmaceutical Limited.
 
Yuqin Song
No Relationships to Disclose